what does syngene international do

Syngene International is a Contract Research, Development, and Manufacturing Organization (CRDMO) that offers end-to-end services for drug discovery, development, and manufacturing, with a total infrastructure of 1.9 million square feet across various locations in India and the US.

what does syngeneic mean in medical terms

In medical terms, syngeneic refers to tissues or cells derived from genetically identical individuals, often used in transplantation studies between genetically identical organisms to avoid immune rejection.

what does syngeneic mouse model mean

A syngeneic mouse model involves using mice that are genetically identical to each other, allowing for consistent immune responses and reducing variability in research, particularly in cancer and transplantation studies.

what does syngenetic mean in geology

In geology, syngenetic refers to rock formations or features that develop simultaneously from the same sedimentary environment or process, such as co-genetic structures like cross-bedding or mud cracks in the same layer.

what does syngeneic transplant mean

A syngeneic transplant is a type of organ or tissue transplantation between genetically identical individuals, minimizing the risk of immune rejection and commonly used in research and certain medical treatments.

SYNGENE

NSEBSE

Syngene International Limited

Healthcare· Healthcare Services· INE398R01022· Scrip: 539268

EN हिन्दी ગુજરાતી मराठी

₹૪૬૮.૦૫

▲ 35.90 (+8.31%)

1/5/2026, 3:28:57 pm

NSE

₹૪૬૮.૦૫

▲ ૩૫.૯૦

+૮.૩૧%

BSE

₹૪૬૭.૯૦

▲ ૩૫.૮૫

+૦.૦૦%

૨૪૪ ટ્રેડિંગ દિવસ · 1Y સમયગાળો

આજ 

ખૂલ્લ૪૩૧.૯૫

ઊંચ૫૧૮.૫૫

નીચ૪૨૯.૯૦

અગાઉ બંધ૪૩૨.૧૫

વૉલ્યુમ૫.૯૩Cr

મૂલ્ય₹૨૮૬૧.૦Cr

L: 429.90H: 518.55

52 સપ્તાહ

નીચ₹૩૮૦.૦૦

ઊંચ₹૭૨૮.૬૦

૨૫% 52 સપ્તાહ રેન્જમાં

માહિતી

અંકિત મૂલ્ય₹૧૦

સૂચિબદ્ધ2015-08-11

ISININE398R01022

SeriesA

BSE સ્ક્રિપ539268

મુખ્ય સૂચકો

1D

+8.31%

1W

+9.27%

1M

+17.35%

3M

-22.76%

6M

-26.71%

મૂલ્યાંકન

P/E (TTM)૩૭.૫૯

P/E (Qtr Ann.)૩૫.૭૮

P/Sales૪.૫૫

બજાર મૂડી₹15840 Cr

વૃદ્ધિ (ત્રિ.)

આવક+5.91%

PAT+23.56%

EPS+23.86%

નફાકારકતા

EBITDA માર્જિન૩૦.૭%

ચોખ્ખો માર્જિન૧૩.૯%

TTM EBITDA M.૩૦.૧%

TTM ચોખ્ખો M.૧૪.૪%

ડિવિડન્ડ

યીલ્ડ૦.૨૭%

છેલ્લો DPS₹૧.૨૫

ચૂકવણી ગુણોત્તર૩૮.૨%

વૃદ્ધિ+0.00%

TTM આવક

₹3478 Cr

TTM EBITDA

₹1048 Cr

TTM PAT

₹500 Cr

TTM EPS

₹૧૨.૪૫

પ્રતિ શેર આવક

₹૮૬.૩

ત્રિમાસિક નાણાકીય

આવક

EBITDA

PAT

EPS

ત્રિમાસ	આવક	Expenses	EBITDA	PBT	PAT	EPS
2024-12-31	944 Cr	781 Cr	290 Cr	181 Cr	131 Cr	₹3.27
2024-09-30	891 Cr	770 Cr	248 Cr	137 Cr	106 Cr	₹2.64
2024-06-30	727 Cr	677 Cr	191 Cr	99 Cr	74 Cr	₹1.84
2024-03-31	917 Cr	724 Cr	320 Cr	209 Cr	189 Cr	₹4.70
2023-12-31	854 Cr	741 Cr	246 Cr	138 Cr	112 Cr	₹2.78
2023-09-30	910 Cr	774 Cr	255 Cr	151 Cr	117 Cr	₹2.90
2023-03-31	994 Cr	786 Cr	327 Cr	231 Cr	179 Cr	₹4.46
2022-12-31	786 Cr	663 Cr	235 Cr	140 Cr	110 Cr	₹2.74

શેરહોલ્ડિંગ પેટર્ન

વર્તમાન — 2026-03-31

પ્રમોટર52.7%

FII13.9%

DII26.4%

સાર્વજનિક47.0%

પ્રમોટર હોલ્ડિંગ ટ્રેન્ડ

કોર્પોરેટ ક્રિયાઓ

એક્સ-તારીખ	પ્રકાર	હેતુ
2025-06-27	Dividend	Dividend - Rs 1.25 Per Share
2024-06-28	Dividend	Dividend - Rs 1.25 Per Share
2023-06-30	Dividend	Dividend - Rs 0.50 Per Share/Special Dividend - Rs 0.75 Per Share
2022-06-30	Dividend	Dividend - Rs 0.50 Per Share/Special Dividend - Rs 0.50 Per Share
2021-07-13	Other	Annual General Meeting
2019-07-16	Dividend	Dividend - Rs 0.50 Per Share
2019-06-11	Bonus	Bonus 1:1
2018-07-17	Dividend	Dividend Re - Re 1 Per Share
2017-07-20	Dividend	Dividend - Rs 1/- Per Share
2016-03-17	Dividend	Interim Dividend - Re 1/- Per Share (Purpose Revised)

કમાણી ટ્રાન્સક્રિપ્ટ

Syngene International Limited has informed the Exchange about Investor Presentation

30 Apr 2026NSE34K chars

Read →

Syngene International Limited has informed the Exchange about Investor Presentation

17 Dec 2025NSE18K chars

Read →

Syngene International Limited has informed the Exchange about Investor Presentation

6 Nov 2025NSE33K chars

Read →

Syngene International Limited has informed the Exchange about Investor Presentation

9 Sept 2025NSE11K chars

Read →

Syngene International Limited has informed the Exchange about Investor Presentation

24 Jul 2025NSE32K chars

Read →

Syngene International Limited has informed the Exchange about Investor Presentation

12 Mar 2025NSE13K chars

Read →

Syngene International Limited has informed the Exchange about Investor Presentation

23 Jan 2025NSE32K chars

Read →

Syngene International Limited has informed the Exchange regarding 'Revised Intimation of Conference ...

17 Jan 2025NSE6K chars

Read →

Syngene International Limited has informed the Exchange about Investor Presentation

25 Jan 2024NSE32K chars

Read →

Syngene International Limited has informed the Exchange about Investor Presentation

17 Oct 2023NSE32K chars

Read →

Syngene International Limited has informed the Exchange about Investor Presentation

26 Jul 2023NSE33K chars

Read →

Syngene International Limited has informed the Exchange about link for the audio recording of the Q4...

27 Apr 2023NSE2K chars

Read →

Syngene International Limited has informed the Exchange about Investor Presentation

26 Apr 2023NSE37K chars

Read →

Syngene International Limited has informed the Exchange about Investor Presentation

23 Jan 2023NSE37K chars

Read →

Syngene International Limited has informed the Exchange about Transcript of Analysts/Institutional I...

25 Oct 2022NSE1K chars

Read →

Syngene International Limited has informed the Exchange about Investor Presentation

19 Oct 2022NSE36K chars

Read →

Syngene International Limited has informed the Exchange about Transcript of Analysts/Institutional I...

26 Jul 2022NSE1K chars

Read →

Syngene International Limited has informed the Exchange about Investor Presentation

20 Jul 2022NSE40K chars

Read →

Syngene International Limited has informed the Exchange about Transcript of Analysts/Institutional I...

4 May 2022NSE2K chars

Read →

Syngene International Limited has informed the Exchange about Investor Presentation

27 Apr 2022NSE45K chars

Read →

ભાવ ઇતિહાસ

તારીખ	ખૂલ્લ	ઊંચ	નીચ	બંધ	વૉલ્યુમ
2026-04-30	૪૩૧.૯૫	૫૧૮.૫૫	૪૨૯.૯૦	૪૬૭.૬૫	૫.૯૩Cr
2026-04-29	૪૪૦.૨૫	૪૪૩.૯૫	૪૨૯.૯૦	૪૩૨.૧૫	૬.૩૧L
2026-04-28	૪૩૫.૦૦	૪૪૫.૬૦	૪૩૪.૧૦	૪૪૦.૨૫	૮.૧૭L
2026-04-27	૪૨૩.૦૦	૪૪૦.૯૦	૪૨૧.૨૫	૪૩૭.૯૫	૬.૪૮L
2026-04-24	૪૩૦.૦૦	૪૩૨.૫૫	૪૧૭.૪૫	૪૨૧.૨૦	૬.૪૮L
2026-04-23	૪૩૧.૦૦	૪૪૨.૪૦	૪૨૭.૦૦	૪૨૮.૩૫	૮.૪૯L
2026-04-22	૪૪૮.૦૦	૪૪૯.૭૦	૪૩૦.૦૦	૪૩૫.૯૫	૭.૪૪L
2026-04-21	૪૩૬.૦૦	૪૫૦.૯૫	૪૩૪.૮૫	૪૪૪.૬૫	૯.૯૮L
2026-04-20	૪૪૦.૦૦	૪૪૩.૫૦	૪૩૩.૧૫	૪૩૬.૪૫	૪.૪૬L
2026-04-17	૪૩૮.૯૦	૪૪૧.૫૦	૪૩૦.૮૦	૪૩૬.૬૦	૫.૩૯L
2026-04-16	૪૧૭.૯૫	૪૩૯.૨૫	૪૧૭.૯૫	૪૩૪.૭૦	૧૪.૬૪L
2026-04-15	૪૦૭.૪૦	૪૧૮.૩૦	૪૦૫.૦૦	૪૧૫.૦૦	૯.૩૬L
2026-04-13	૪૦૦.૦૦	૪૦૩.૯૦	૩૯૧.૭૫	૪૦૨.૮૫	૫.૧૧L
2026-04-10	૩૯૯.૦૦	૪૧૧.૮૦	૩૯૫.૧૦	૪૦૪.૬૫	૨૫.૬૮L
2026-04-09	૪૦૨.૪૦	૪૦૫.૪૦	૩૯૦.૨૫	૩૯૩.૧૦	૯.૩૬L
2026-04-08	૩૯૯.૪૫	૪૦૨.૪૦	૩૯૫.૬૫	૩૯૯.૦૫	૧૭.૫૯L
2026-04-07	૪૦૦.૦૦	૪૦૨.૩૦	૩૯૦.૦૦	૩૯૦.૯૦	૧૫.૦૬L
2026-04-02	૩૯૨.૫૫	૩૯૩.૨૦	૩૮૦.૦૫	૩૯૧.૧૦	૫.૩૬L
2026-04-01	૩૯૫.૦૫	૪૦૪.૫૦	૩૯૦.૪૫	૩૯૬.૪૦	૧૩.૭૭L
2026-03-27	૪૧૯.૦૦	૪૨૬.૧૫	૪૦૨.૭૫	૪૧૫.૬૦	૪૦.૨૦L
2026-03-25	૪૦૨.૦૦	૪૨૩.૩૦	૪૦૨.૦૦	૪૧૮.૭૫	૨૭.૪૮L
2026-03-24	૪૦૨.૫૦	૪૦૬.૧૫	૩૯૫.૦૫	૩૯૮.૮૫	૯.૦૯L
2026-03-20	૪૦૭.૮૫	૪૧૭.૮૦	૪૦૭.૮૫	૪૧૪.૭૫	૧૦.૮૫L
2026-03-19	૪૧૫.૦૦	૪૧૯.૮૦	૪૦૬.૨૫	૪૦૭.૮૫	૫.૭૫L
2026-03-18	૪૧૨.૧૦	૪૨૬.૩૫	૪૧૨.૧૦	૪૧૯.૮૫	૮.૯૪L
2026-03-17	૪૦૯.૫૦	૪૧૫.૩૦	૪૦૭.૮૦	૪૧૧.૦૫	૮.૧૮L
2026-03-16	૪૨૪.૩૫	૪૨૬.૨૦	૪૦૫.૪૫	૪૧૦.૧૫	૧૮.૦૬L
2026-03-13	૪૦૫.૯૦	૪૨૮.૦૦	૪૦૫.૦૦	૪૨૦.૮૫	૯૭.૮૭L
2026-03-12	૪૦૭.૩૦	૪૦૮.૬૦	૩૯૬.૨૦	૪૦૪.૧૦	૬.૩૨L
2026-03-11	૪૦૯.૦૦	૪૧૬.૮૫	૪૦૫.૫૦	૪૦૮.૧૫	૬.૧૫L

વારંવાર પૂછાતા પ્રશ્નો

વિશે

Syngene ઈન્ટરનેશનલ લિમિટેડ, નેશનલ સ્ટોક એક્સચેન્જ ઓફ ઈન્ડિયા (NSE) પર SYNGENE તરીકે સૂચિબદ્ધ, એક અગ્રણી કોન્ટ્રાક્ટ સંશોધન અને ઉત્પાદન કંપની છે જે ભારત, યુનાઈટેડ સ્ટેટ્સ, યુરોપ અને આંતરરાષ્ટ્રીય સ્તરે ફેલાયેલી કામગીરી સાથે દવાની શોધ અને વિકાસ સેવાઓમાં વિશેષતા ધરાવે છે. કંપની વૈવિધ્યપૂર્ણ સ્ક્રિનિંગ, ફ્રેગમેન્ટ-આધારિત દવા ડિઝાઇન, અને સેલ અને જીન થેરાપી સોલ્યુશન્સ, ફાર્માસ્યુટિકલ અને બાયોટેકનોલોજી ઉદ્યોગોને કેટરિંગ સહિતની મુખ્ય સેવાઓ પ્રદાન કરે છે.

BOARD OF DIRECTORS

Carl Decicco

Executive Director

DEPARTED

Sibaji Biswas

Executive Director

DEPARTED

Vinita Bali

Executive Director

Manja Boerman

Independent Director

Nilanjan Roy

Independent Director

Sharmila Abhay Karve

Independent Director

Kiran Mazumdar Shaw